Video Experimental Relacionado
Updated: Jan 13, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Knock-out de isoformas específicas del gen DMD en la línea parental de CCE SA001 utilizando CRISPR/Cas9
Laure Chatrousse1, Thifaine Poullion1, Hamel Mahiou2
1CECS, I-STEM, AFM, Neuroplasticity and Therapeutics, 91100 Corbeil-Essonnes, France.
Abstract:
The DMD gene, which encodes the protein dystrophin, is involved in a group of diseases known as dystrophinopathies, which includes Duchenne Muscular Dystrophy (DMD). DMD is a progressive and lethal muscular disorder mainly affecting boys that results from the loss of function of the longer dystrophin isoform DP427 in skeletal muscles. Dystrophinopathies are also associated with poorly understood neurocognitive and neurodevelopmental disorders. To investigate the role of dystrophin isoforms in neural development, we specifically disrupted three dystrophin isoforms expressed in the brain, namely DP427, DP140 and DP71, in the male human embryonic stem cell line SA001 using the CRISPR/Cas9 system. (100 / 100 words).

